MindMed Inks Deal With Switzerland University For Rights On LSD Research

Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NEO: MMED) (OTC: MMEDF) has acquired exclusive rights to data, compounds, and patents for research with LSD and other psychedelics from the Liechti laboratory in Switzerland’s University Hospital Basel.

Read full article:

https://finance.yahoo.com/news/mindmed-inks-deal-switzerland-university-182325900.html